Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1511-1520 of 1772 for

Edit search filters
  1. A Study To Analyze Symptoms And Quality Of Life Issues In Women Living With Metastatic Breast Cancer

    Jacksonville, FL

  2. A Study To Quantify Microvasculature Imaging For Breast Cancer Detection And Monitoring

    Rochester, MN

  3. A Study To Evaluate The Role Of Gut Microbiome In Cancer Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. GENetic Risk Estimation Of Breast Cancer Prior To Decisions On Preventive Therapy Uptake, Risk Reducing Surgery Or Intensive Imaging Surveillance

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Austin, MN, Jacksonville, FL, Rochester, MN

  5. Long Term Outcomes In Pancreas Cancer Patients

    Rochester, MN

  6. A Study To Determine The Effects Of COVID-19 In Cancer Patients

    Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  7. Optimizing Pancreatic Cancer Management Using Next Generation Imaging And Liquid Biopsy

    Rochester, MN

  8. A Study To Assess Dynamic Changes In Plasma Proteome To Identify Early Detection And Treatment Response Biomarkers For HGSOC

    Rochester, MN

  9. CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR)

    Rochester, MN

  10. A Study Of Patients Undergoing Neoadjuvant Therapy For Resectable Non-small Cell Lung Cancer To Evaluate Perioperative Circulating Tumor DNA As A Prognostic Biomarker

    Jacksonville, FL

.

Mayo Clinic Footer